Ulland Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Ulland Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Hold	40	–	–	0.01%	161
2026 Q1	$20K	Hold	40	–	–	0.02%	156
2025 Q4	$23K	Hold	40	–	–	0.02%	148
2025 Q3	$19K	Buy	+40	New	+$18.6K	0.01%	156
2024 Q1	–	Sell	-30	Closed	-$16K	–	256
2023 Q4	$16K	Hold	30	–	–	0.02%	147
2023 Q3	$15K	Hold	30	–	–	0.02%	158
2023 Q2	$16K	Hold	30	–	–	0.02%	148
2023 Q1	$17K	Hold	30	–	–	0.02%	139
2022 Q4	$17K	Hold	30	–	–	0.02%	144
2022 Q3	$15K	Hold	30	–	–	0.02%	146
2022 Q2	$16K	Hold	30	–	–	0.02%	155
2022 Q1	$18K	Buy	+30	New	+$17.2K	0.01%	161

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Ulland Investment Advisors's TMO Position: Q2 2026 in Review

Ulland Investment Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 40 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #161.

Ulland Investment Advisors first reported a position in TMO in Q1 2022 and has held it in 12 quarters since. The position peaked at $23K in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Ulland Investment Advisors held 40 shares of Thermo Fisher Scientific worth $20K as of Q2 2026.
Ulland Investment Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.01% of Ulland Investment Advisors's portfolio in Q2 2026, its #161 holding.
Ulland Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 12 quarters since.
Ulland Investment Advisors's Thermo Fisher Scientific position peaked at $23K in Q4 2025.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.